Crossmark

Bioenzyme-based nanomedicines for enhanced cancer therapy

Crossref DOI link: https://doi.org/10.1186/s40580-022-00297-8

Published Online: 2022-02-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ding, Mengbin

Zhang, Yijing

Li, Jingchao

Pu, Kanyi https://orcid.org/0000-0002-8064-6009
License Information

Text and Data Mining valid from 2022-02-04

Version of Record valid from 2022-02-04
More Information

Article History

Received: 14 November 2021

Accepted: 4 January 2022

First Online: 4 February 2022

Declarations

:

: The authors declare that they have no competing interests.